2,607
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Zhizhu decoction alleviates slow transit constipation by regulating aryl hydrocarbon receptor through gut microbiota

ORCID Icon, , , , , , & show all
Pages 111-124 | Received 05 May 2022, Accepted 03 Dec 2022, Published online: 23 Dec 2022

References

  • Anzenbacher P, Anzenbacherová E. 2001. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci. 58(5–6):737–747.
  • Biancani P, Beinfeld MC, Coy DH, Hillemeier C, Walsh JH, Behar J. 1988. Dysfunction of the gastrointestinal tract. Vasoactive intestinal peptide in peristalsis and sphincter function. Ann N Y Acad Sci. 527:546–567.
  • Black CJ, Ford AC. 2018. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust. 209(2):86–91.
  • Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simrén M, Lembo A, Young-Fadok TM, Chang L. 2017. Chronic constipation. Nat Rev Dis Primers. 3:17095.
  • Cervantes-Barragan L, Colonna M. 2018. AHR signaling in the development and function of intestinal immune cells and beyond. Semin Immunopathol. 40(4):371–377.
  • Chen J, Liu X, Dou D-Q. 2016. Bidirectional effective components of Atractylodis macrocephalae rhizoma on gastrointestinal peristalsis. International J of Pharmacology. 12(2):108–115.
  • Chinen I, Nakahama T, Kimura A, Nguyen NT, Takemori H, Kumagai A, Kayama H, Takeda K, Lee S, Hanieh H, et al. 2015. The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. Int Immunol. 27(8):405–415.
  • Delescluse C, Lemaire G, de Sousa G, Rahmani R. 2000. Is CYP1A1 induction always related to AHR signaling pathway? Toxicology. 153(1–3):73–82.
  • Deng Z, Fu Z, Yan W, Nie K, Ding L, Ma D, Huang H, Li T, Xie J, Fu L. 2021. The different effects of Chinese herb solid drink and lactulose on gut microbiota in rats with slow transit constipation induced by compound diphenoxylate. Food Res Int. 143:110273.
  • Dimidi E, Christodoulides S, Scott SM, Whelan K. 2017. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr. 8(3):484–494.
  • Dinan TG, Cryan JF. 2017. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am. 46(1):77–89.
  • Furness JB. 2012. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 9(5):286–294.
  • Ganci M, Suleyman E, Butt H, Ball M. 2019. The role of the brain-gut-microbiota axis in psychology: the importance of considering gut microbiota in the development, perpetuation, and treatment of psychological disorders. Brain Behav. 9(11):e01408.
  • Ge X, Zhao W, Ding C, Tian H, Xu L, Wang H, Ni L, Jiang J, Gong J, Zhu W, et al. 2017. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep. 7(1):441.
  • Gershon MD, Tack J. 2007. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 132(1):397–414.
  • Guengerich FP. 2006. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 8(1):E101–111.
  • He W, Zhang Y, Wang X, Guo L, Han L, Liu E, Wang T. 2013. Zhizhu decoction promotes gastric emptying and protects the gastric mucosa. J Med Food. 16(4):306–311.
  • Huang A, Chi Y, Zeng Y, Liping LU. 2012. Influence of fructus Aurantii immaturus flavonoids on gastrointestinal motility in rats with functional dyspepsia. Tradit Chin Drug Res Pharmacol. 23:612–615.
  • Hyland NP, Cryan JF. 2016. Microbe-host interactions: influence of the gut microbiota on the enteric nervous system. Dev Biol. 417(2):182–187.
  • Ingelman-Sundberg M. 2004. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn Schmiedebergs Arch Pharmacol. 369(1):89–104.
  • Iwasaki M, Akiba Y, Kaunitz JD. 2019. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Res. 8:1629.
  • Jang Y, Kim TK, Shim WS. 2013. Naringin exhibits in vivo prokinetic activity via activation of ghrelin receptor in gastrointestinal motility dysfunction rats. Pharmacology. 92(3–4):191–197.
  • Jani B, Marsicano E. 2018. Constipation: evaluation and management. Mo Med. 115(3):236–240.
  • Khalif IL, Quigley EM, Konovitch EA, Maximova ID. 2005. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 37(11):838–849.
  • Lee JH, Lee SH, Kim YS, Jeong CS. 2009. Protective effects of neohesperidin and poncirin isolated from the fruits of Poncirus trifoliata on potential gastric disease. Phytother Res. 23(12):1748–1753.
  • Li DY, Dai YK, Zhang YZ, Huang MX, Li RL, Ou-Yang J, Chen WJ, Hu L. 2017. Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome. PLOS One. 12(12):e0189491.
  • Lin LW, Fu YT, Dunning T, Zhang AL, Ho TH, Duke M, Lo SK. 2009. Efficacy of traditional Chinese medicine for the management of constipation: a systematic review. J Altern Complement Med. 15(12):1335–1346.
  • Obata Y, Castaño Á, Boeing S, Bon-Frauches AC, Fung C, Fallesen T, de Agüero MG, Yilmaz B, Lopes R, Huseynova A, et al. 2020. Neuronal programming by microbiota regulates intestinal physiology. Nature. 578(7794):284–289.
  • Ohkusa T, Koido S, Nishikawa Y, Sato N. 2019. Gut microbiota and chronic constipation: a review and update. Front Med. 6:19.
  • Rothhammer V, Quintana FJ. 2019. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol. 19(3):184–197.
  • Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, et al. 2017. Feedback control of AHR signalling regulates intestinal immunity. Nature. 542(7640):242–245.
  • Sharma A, Rao S. 2017. Constipation: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol. 239:59–74.
  • Shi N, Li N, Duan X, Niu H. 2017. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 4:14.
  • Spencer NJ, Hu H. 2020. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 17(6):338–351.
  • Stockinger B, Di Meglio P, Gialitakis M, Duarte JH. 2014. The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol. 32:403–432.
  • Sun M, Ma N, He T, Johnston LJ, Ma X. 2020. Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Crit Rev Food Sci Nutr. 60(10):1760–1768.
  • Tan W, Li Y, Wang Y, Zhang Z, Wang T, Zhou Q, Wang X. 2017. Anti-coagulative and gastrointestinal motility regulative activities of fructus Aurantii immaturus and its effective fractions. Biomed Pharmacother. 90:244–252.
  • Tian H, Ding C, Gong J, Ge X, McFarland LV, Gu L, Wei Y, Chen Q, Zhu W, Li J, et al. 2016. Treatment of slow transit constipation with fecal microbiota transplantation: a pilot study. J Clin Gastroenterol. 50(10):865–870.
  • Turner DJ, Martin PC, Rao JN, Greenspon J, Zou T, Bass BL, Wang JY, Strauch ED. 2007. Substance P regulates migration in rat intestinal epithelial cells. Ann Surg. 245(3):408–414.
  • Wang HL. 2015. Understanding the pathogenesis of slow-transit constipation: one step forward. Dig Dis Sci. 60(8):2216–2218.
  • Wang KT, Chen LG, Wu CH, Chang CC, Wang CC. 2010. Gastroprotective activity of atractylenolide III from Atractylodes ovata on ethanol-induced gastric ulcer in vitro and in vivo. J Pharm Pharmacol. 62(3):381–388.
  • Wang C, Ren Q, Chen XT, Song ZQ, Ning ZC, Gan JH, Ma XL, Liang DR, Guan DG, Liu ZL, et al. 2018. System pharmacology-based strategy to decode the synergistic mechanism of Zhi-zhu Wan for functional dyspepsia. Front Pharmacol. 9:841.
  • Wang JK, Yao SK. 2021. Roles of gut microbiota and metabolites in pathogenesis of functional constipation. Evid Based Complement Alternat Med. 2021:5560310.
  • Wang C, Zhu M, Xia W, Jiang W, Li Y. 2012. Meta-analysis of traditional Chinese medicine in treating functional dyspepsia of liver-stomach disharmony syndrome. J Tradit Chin Med. 32(4):515–522.
  • Wattchow D, Brookes S, Murphy E, Carbone S, de Fontgalland D, Costa M. 2008. Regional variation in the neurochemical coding of the myenteric plexus of the human colon and changes in patients with slow transit constipation. Neurogastroenterol Motil. 20(12):1298–1305.
  • Wen Y, Zhan Y, Tang SY, Liu F, Wang QX, Kong PF, et al. 2022. Zhizhu decoction alleviates intestinal barrier damage via regulating SIRT1/FoxO1 signaling pathway in slow transit constipation model mice. Chin J Integr Med. Online ahead of print.
  • Wu H, Jing Z, Tang X, Wang X, Zhang S, Yu Y, Wang Z, Cao H, Huang L, Yu Y, et al. 2011. To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized group sequential comparative trial. BMC Gastroenterol. 11:81.
  • Yik YI, Farmer PJ, King SK, Chow CW, Hutson JM, Southwell BR. 2011. Gender differences in reduced substance P (SP) in children with slow-transit constipation. Pediatr Surg Int. 27(7):699–704.
  • Yoo BB, Mazmanian SK. 2017. The Enteric Network: interactions between the immune and nervous systems of the gut. Immunity. 46(6):910–926.
  • Zhang S, Wang R, Li D, Zhao L, Zhu L. 2021. Role of gut microbiota in functional constipation. Gastroenterol Rep. 9(5):392–401.